Phase II study of the A-ICOX regimen [bevacizumab (Bev), weekly intermittent capecitabine (Cap) and oxaliplatin (Ox)] for untreated advanced colorectal cancer (CRC)

被引：0
|
作者：
Ramanathan, R. K. [1 ]
Rajasenan, K. [1 ]
Crandall, T. [1 ]
Balaban, E. P. [1 ]
Pinkerton, R. A. [1 ]
Kane, P. [1 ]
Potter, D. M. [1 ]
Dranko, S. [1 ]
Schmotzer, A. [1 ]
Lembersky, B. C. [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4092
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of bevacizumab (BEV), weekly (wkly) intermittent capecitabine (Cap), and oxaliplatin (Ox) on an every-2-week schedule for patients (Pts) with untreated advanced colorectal cancer (CRC)
    Lembersky, B. C.
    Sehgal, R.
    Rajasenan, K. K.
    Crandall, T. L.
    Balaban, E. P.
    Pinkerton, R. A.
    Kane, P.
    Potter, D. M.
    Kinney, C.
    Ramanathan, R. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase I/II study of weekly intermittent capecitabine with bevacizumab and oxaliplatin on an every-2-week schedule for patients with untreated advanced colorectal cancer (CRC) final results
    Ramanathan, R. K.
    Sehgal, R.
    Rajasenan, K. K.
    Crandall, T. L.
    Balaban, E. P.
    Pinkerton, R. A.
    Kane, P.
    Potter, D. M.
    Lembersky, B. C.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 339 - 339
  • [3] A phase ii study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer
    Bendell, J.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Vaccaro, G.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 67 - 67
  • [4] Phase I/II trial of capecitabine (Cap) and oxaliplatin (Ox) in combination with bevacizumab (Bev) and imatinib (Ima) in patients with metastatic colorectal cancer (CRC): AIO KRK 0205
    von Wichert, G.
    Hoehler, T.
    Schimanski, C. C.
    Moehler, M. H.
    Hofheinz, R.
    Kanzler, S.
    Hinke, A.
    Seufferlein, T.
    Siebler, J.
    Hochhaus, A.
    Arnold, D.
    Hallek, M.
    Hacker, U. T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A phase II study of oxaliplatin (OX), capecitabine (CAP), and bevacizumab (BV) in the treatment of metastatic colorectal cancer.
    Bendell, J. C.
    Fernando, N.
    Morse, M.
    Blobe, G.
    Yu, D.
    Sutton, L.
    Schaffer, S.
    Honeycutt, W.
    Franklin, A.
    Hurwitz, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 156S - 156S
  • [6] Activity of the combination of bevacizumab (Bev) with capecitabine/irinotecan (CapIri/Bev) or capecitabine/oxaliplatin (CapOx/Bev) in advanced colorectal cancer (ACRC): A randomized phase II study of the AIO Colorectal Study Group (AIO trial 0604)
    Reinacher-Schick, A. C.
    Kubicka, S.
    Freier, W.
    Arnold, D.
    Dietrich, G.
    Geissler, M.
    Hegewisch-Becker, S.
    Graeven, U.
    Schmoll, H.
    Schmiegel, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Initial results of a phase II study of oxaliplatin (OX), capecitabine (CAP), bevacizumab (BV), and cetuximab (CET) in the treatment of metastatic colorectal cancer (mCRC)
    Bendell, J. C.
    Uronis, H. E.
    Morse, M. A.
    Blobe, G.
    Aklilu, M.
    Nixon, A.
    Niedzweicki, D.
    Honeycutt, W.
    Howard, L.
    Hurwitz, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [9] A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer
    Hurwitz, H
    Fernando, N
    Yu, DH
    Morse, M
    Blobe, G
    Gockerman, J
    Odogwu, L
    Mahon, M
    Truax, R
    Franklin, A
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 285 - 285
  • [10] A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer
    Sehgal, Rajesh
    Lembersky, Barry C.
    Rajasenan, Kiran K.
    Crandall, Theodore L.
    Balaban, Edward P.
    Pinkerton, Richard A.
    Kane, Patrick
    Schmotzer, Amy
    Zeh, Herbert
    Potter, Douglas M.
    Ramanathan, Ramesh K.
    [J]. CLINICAL COLORECTAL CANCER, 2011, 10 (02) : 117 - 120
12345